Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000278 · ClinicalTrials.gov registry record · Phase 2
Disulfiram for Cocaine-Alcohol Abuse - 3
A Phase 2 study of Cocaine-Related Disorders and Alcohol-Related Disorders, sponsored by Yale University.
- Completed
- Registry status
- Phase 2
- Development phase
- 1
- Study location
NCT00000278 is a Phase 2 study of Cocaine-Related Disorders and Alcohol-Related Disorders that has completed, run by Yale University. The trial reports 1 study location across 1 state.
The verdict
NCT00000278, a Phase 2 study of Cocaine-Related Disorders and Alcohol-Related Disorders, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 1
- Study location
Study Summary
The purpose of this study is to evaluate disulfiram for cocaine-alcohol abuse.
Conditions Studied
Interventions
- DRUG Disulfiram
Study Locations (1)
Connecticut
- VA Connecticut Healthcare System - New Haven
Trial Details
| Field | Value |
|---|---|
| Start Date | 1994-09 |
| Est. Completion | 1999-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00000278
The ClinicalTrials.gov registry entry for NCT00000278 describes a study currently listed as completed, categorized as Phase 2. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Cocaine-Related Disorders appearing as the primary indexed condition, and to 1 intervention - of which Disulfiram is the first listed.
NCT00000278 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT00000278 about?
NCT00000278 is a clinical study titled "Disulfiram for Cocaine-Alcohol Abuse - 3". The purpose of this study is to evaluate disulfiram for cocaine-alcohol abuse.
What is the current status of trial NCT00000278?
This trial is currently completed. It is a Phase 2 study. The study started on 1994-09. Estimated completion is 1999-08.
What conditions does trial NCT00000278 study?
This clinical trial studies the following conditions: Cocaine-Related Disorders, Alcohol-Related Disorders.
What interventions are being tested in trial NCT00000278?
The interventions under investigation include: Disulfiram (DRUG).
Who is sponsoring clinical trial NCT00000278?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00000278 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cocaine-Related Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Developing Adaptive Interventions for Cocaine Cessation and Relapse Prevention
COMPLETED · Phase 2
-
Atomoxetine for Treating Cocaine Abuse in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
COMPLETED · Phase 2
-
Pharmacological Modulation of Cocaine Effects - 1
COMPLETED · Phase 2
-
Gepirone vs Placebo in Treatment of Cocaine Dependence - 3
COMPLETED · Phase 2
-
Risperidone Treatment in Dually-Diagnosed Individuals - 2
COMPLETED · Phase 2
-
Combination of Disulfiram Plus Naltrexone to Treat Both Cocaine- and Alcohol-dependent Individuals - 1
COMPLETED · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.